Jyothy Labs Limited (JYOTHYLAB) AI Stock Analysis

• Market Cap: ₹115.87B
• Dividend Yield: 1.12%
• Average Volume (3M): 26.54K
• Price to Earnings (P/E): 31.7
• Beta (1Y): 0.80
• Revenue Growth: 1.59%
• EPS Growth: -2.52%
• Country: IN
• Employees: 2,943
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Household & Personal Products
• EPS (TTM): 2.60
• Shares Outstanding: 367,214,500
• 10 Day Avg. Volume: 19,687
• 30 Day Avg. Volume: 26,541
• PEG Ratio: 109.35
• Price to Book (P/B): 5.89
• Price to Sales (P/S): 4.21
• P/FCF Ratio: 47.69
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ₹414.67
• Price Target Upside: 32.80% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 3
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 68 Neutral
• Price Target: ₹367.00 ▲(17.53% Upside)

Jyothy Labs Limited's overall stock score is driven primarily by its strong financial performance, which is a key strength. However, the technical analysis indicates mixed signals, and the valuation suggests potential overvaluation, which tempers the overall score. The absence of earnings call data and notable corporate events means these factors do not influence the score.

Jyothy Labs Limited Business Overview & Revenue Model

Company Description

Jyothy Labs Limited (JYOTHYLAB) is an Indian consumer goods company that specializes in the manufacturing and marketing of a diverse range of products primarily in the home care, personal care, and fabric care segments. Founded in 1983, the company has established a strong presence in the Indian market and is known for its flagship brands such as Ujala, Maxo, and Exo, which cater to everyday household needs. JYOTHYLAB operates across various categories including detergents, soaps, mosquito repellents, and other personal care products, focusing on innovation and quality to meet consumer demands.

How the Company Makes Money

Jyothy Labs generates revenue primarily through the sale of its consumer products in domestic and international markets. The company's revenue model is based on the direct sale of branded goods through various distribution channels, including modern retail, traditional trade, and e-commerce platforms. Key revenue streams include fabric care products (such as detergents and fabric whiteners), personal care products (soaps and shampoos), and insecticides (mosquito repellents). Additionally, JYOTHYLAB benefits from strong brand recognition and customer loyalty, which drive repeat purchases. Strategic partnerships with distributors and retailers enhance its market reach and visibility. The company also focuses on innovation and product development, launching new products that cater to changing consumer preferences, further contributing to its earnings.

Jyothy Labs Limited Financial Statement Overview

Summary

Jyothy Labs Limited exhibits strong financial performance with consistent revenue and profit growth, effective cost management, and solid cash flow generation. The balance sheet is robust with low leverage, although a high equity ratio could limit financial flexibility. The company should focus on maintaining cash flow efficiency to sustain growth momentum.

Income Statement

Jyothy Labs Limited shows strong revenue growth with a consistent increase from INR 17,097 million in 2020 to INR 28,469 million in 2025. The gross profit margin has improved significantly, indicating efficient cost management and pricing strategies. Net profit margin has also remained stable, contributing to overall profitability. The EBIT and EBITDA margins reflect robust operational efficiency. However, attention is needed on the slight volatility in EBIT margins over the years.

Balance Sheet

The company maintains a solid balance sheet with a favorable debt-to-equity ratio, decreasing from 0.27 in 2020 to 0.03 in 2025, showcasing effective debt management and strong equity base. The return on equity is commendable, enhancing investor confidence. However, the equity ratio suggests a high reliance on equity financing, which could limit leverage benefits.

Cash Flow

Jyothy Labs has demonstrated strong cash flow generation with positive free cash flow growth. The operating cash flow to net income ratio indicates efficient conversion of income into cash, although there was a decline in operating cash flow in recent years. The company's free cash flow to net income ratio is solid, reflecting effective capital expenditure management. However, the decline in operating cash flow from 2024 to 2025 suggests potential challenges in cash generation operations.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	28.78B	28.68B	27.61B	24.86B	21.97B	19.10B
Gross Profit	14.19B	14.39B	13.48B	10.42B	9.06B	8.92B
EBITDA	4.94B	5.05B	4.74B	3.08B	2.39B	3.09B
Net Income	3.65B	3.70B	3.69B	2.40B	1.62B	1.99B
Balance Sheet
Total Assets	0.00	26.91B	24.01B	20.62B	20.23B	19.56B
Cash, Cash Equivalents and Short-Term Investments	5.99B	5.99B	6.16B	2.81B	2.09B	1.94B
Total Debt	0.00	612.80M	505.60M	465.30M	1.71B	1.67B
Total Liabilities	-20.50B	6.41B	5.91B	5.11B	6.20B	5.65B
Stockholders Equity	20.50B	20.50B	18.08B	15.49B	14.44B	14.29B
Cash Flow
Free Cash Flow	0.00	2.53B	4.21B	2.93B	1.77B	3.76B
Operating Cash Flow	0.00	3.11B	4.58B	3.29B	2.03B	4.02B
Investing Cash Flow	0.00	-1.61B	-3.44B	-482.90M	-317.13M	-1.29B
Financing Cash Flow	0.00	-1.57B	-1.35B	-2.51B	-1.67B	-2.16B

Jyothy Labs Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 312.25
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:JYOTHYLAB, the sentiment is Negative. The current price of 312.25 is below the 20-day moving average (MA) of 315.88, below the 50-day MA of 320.87, and below the 200-day MA of 340.03, indicating a bearish trend. The MACD of -1.27 indicates Positive momentum. The RSI at 41.72 is Neutral, neither overbought nor oversold. The STOCH value of 23.55 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:JYOTHYLAB.

Jyothy Labs Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ZYDUSWELL	73 Outperform	₹143.17B	56.50	―	0.27%	14.55%	-20.61%
JYOTHYLAB	68 Neutral	₹115.87B	31.70	―	1.12%	1.59%	-2.52%
BECTORFOOD	67 Neutral	₹81.26B	58.01	―	0.46%	12.92%	-4.82%
GALAXYSURF	67 Neutral	₹80.47B	26.41	―	0.98%	18.32%	-0.43%
CCL	63 Neutral	₹136.73B	40.38	―	0.49%	30.11%	23.22%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
HONASA	54 Neutral	₹91.54B	124.04	―	―	4.91%	-55.92%

Jyothy Labs Limited Corporate Events

Jyothy Labs Grants Restricted Stock Units to Employees

Jyothy Labs Limited announced the approval of 89,612 Restricted Stock Units (RSUs) under its Employee Stock Unit Plan 2023, granted to selected employees. This initiative, approved by the company’s Nomination, Remuneration and Compensation Committee, aims to align employee incentives with company performance, potentially enhancing employee retention and motivation, thereby impacting the company’s operational efficiency and market positioning.

Jyothy Labs Launches ‘Saksham Niveshak’ Campaign for Shareholders

Jyothy Labs Limited has launched a 100-day campaign named ‘Saksham Niveshak’ to encourage shareholders to update their KYC details and claim any unpaid or unclaimed dividends. This initiative, directed by the Investor’s Education and Protection Fund Authority, aims to prevent the transfer of unclaimed dividends and corresponding equity shares to the Investor Education and Protection Fund, impacting shareholder engagement and compliance.

Jyothy Labs Announces 34th AGM for FY 2024-25

Jyothy Labs Limited has announced the convening of its 34th Annual General Meeting (AGM) for the financial year 2024-25, scheduled for September 11, 2025, to be held via video conferencing. The AGM will cover various business items including the adoption of audited financial statements, declaration of a final dividend, re-appointment of a director, and approval of remuneration for cost auditors. This meeting is significant for stakeholders as it addresses key financial and operational aspects of the company, reflecting its ongoing commitment to transparency and governance.

Jyothy Labs Releases Q1 2025 Financial Call Recording

Jyothy Labs Limited announced the availability of an audio recording from their recent conference call discussing the company’s unaudited financial results for the quarter ended June 30, 2025. This initiative aims to enhance transparency and keep investors informed about the company’s financial performance and strategic direction.